---
title: Biocon vs Rezon Bio
slug_a: biocon
slug_b: rezonbio
site: cdmo
review_signal_gate: closed
canonical_path: /compare/biocon/rezonbio
---

# Biocon vs Rezon Bio

Side-by-side profile data from each company listing on this directory.

## Biocon

- Profile: [/companies/biocon](/companies/biocon)

Biocon — Fully integrated biopharmaceutical company developing affordable biosimilars, generic formulations, and complex APIs for diabetes, cancer, and autoimmune diseases.

Services: 14. Modalities: 2. Indications: 3. Locations: 4. Certifications: 10. The strongest documented coverage currently appears in services (14).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- Biologics Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Upstream Processing
- Downstream Processing
- Microbial Fermentation
- Process Development
- Formulation Development
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian
- Expression: Microbial
- Stainless Steel

## Rezon Bio

- Profile: [/companies/rezonbio](/companies/rezonbio)

Rezon Bio — European biologics CDMO offering end-to-end development and manufacturing across two GMP-certified sites in Poland, with capabilities from cell line development to commercial-scale production.

Services: 9. Modalities: 2. Indications: 0. Locations: 4. Certifications: 2. The strongest documented coverage currently appears in services (9).

### Services

- Regulatory Affairs
- Cell-Line Development
- Upstream Processing
- Downstream Processing
- Process Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)

### Development capabilities

- Analytical method development
- ICH stability testing
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Max bioreactor: Large commercial (≤10,000 L)
- Expression: Mammalian
- Stainless Steel